Literature DB >> 6840187

Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions.

C Lillie, W Kobinger.   

Abstract

Two new substances, alinidine (St 567) and AQ-A 39, previously described as 'specific bradycardic agents' were investigated with respect to their effects on the rate of electrical discharges from sinus nodes of isolated right guinea-pig atria. Both substances decreased the discharge rate concentration dependently within a wide range (3-100 micrograms/ml). Low external Ca2+ (0.18 mM) increased and low external NaCl (62 mM) decreased the rate lowering effect of alinidine as well as of AQ-A 39. In contrast, the reference compound verapamil (an inhibitor of slow inward current) was less effective in low Ca2+ and more effective in low NaCl. The similar reactions of alinidine and AQ-A 39 are discussed with respect to their different chemical structure and different electrophysiological action patterns as described so far.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840187     DOI: 10.1016/0014-2999(83)90046-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Cardiovascular effects of AQ-A 39 in healthy volunteers.

Authors:  J Hilaire; J P Broustet; J P Colle; M Theron
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

2.  Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration.

Authors:  C Lillie; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

3.  On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49.

Authors:  T Doerr; W Trautwein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

4.  Interactions between alinidine and responses to acetylcholine, dopamine and 5-hydroxytryptamine of specific Helix central neurones.

Authors:  A J Bokisch; R J Walker
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

5.  Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.

Authors:  J L Challinor-Rogers; T K Hay; G A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

6.  Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.

Authors:  C Lillie; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

Review 7.  HCN channels and heart rate.

Authors:  Pietro Scicchitano; Santa Carbonara; Gabriella Ricci; Cosimo Mandurino; Manuela Locorotondo; Gabriella Bulzis; Michele Gesualdo; Annapaola Zito; Rosa Carbonara; Ilaria Dentamaro; Graziano Riccioni; Marco Matteo Ciccone
Journal:  Molecules       Date:  2012-04-05       Impact factor: 4.411

8.  Characterization of drug binding within the HCN1 channel pore.

Authors:  Jérémie Tanguay; Karen M Callahan; Nazzareno D'Avanzo
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.